Small molecule-switchable RNA platform enables control of therapeutic protein expression

FHS
January 2, 2024
11:27 am

Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio – Pharmaceutical Technology

Novartis will inherit Mariana’s lead asset MC-339, a radioligand therapy (RLT) designed to target small cell lung cancer. Credit: JHVEPhoto via Shutterstock. Novartis is firming

May 2, 2024

Amicus briefs fly in as IRA ‘fair price’ deadline looms

Amicus briefs are piling up in support of drug price negotiations under the Inflation Reduction Act ahead of a key February deadline by which the

January 17, 2024

Pregnant Patients With T2D See Pluses and Minuses With Semaglutide

AURORA, Colo. — Pregnant patients with type 2 diabetes (T2D) treated with semaglutide (Ozempic) had mixed pregnancy outcomes, an observational study found. Among more than

February 2, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.